It is tempting to speculate that DPP9 inhibition could alleviate other viral infections in which the virus remains dormant in the hosts’ cells, such as hepatitis B virus (HBV) or herpes simplex virus (HSV). This evidence concerns the gene DPP9 and viral infectious disease.